Last reviewed · How we verify
NCT03781024
A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
trial testing Footwash in Toenail Fungal Infection in 5,000 participants. Status unknown.
1 December 2021
Quick facts
| Lead sponsor | Data Collection Analysis Business Management |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 December 2018 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Footwash
Conditions studied
- Toenail Fungal Infection — all drugs for Toenail Fungal Infection →
- Cellulitis — all drugs for Cellulitis →
- Pitted Keratolysis — all drugs for Pitted Keratolysis →
- Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
Sponsor
Data Collection Analysis Business Management
Who can join
Eligibility, any sex, with Toenail Fungal Infection or Cellulitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the level of relief perceived by patients using medicated footbath/footwash with or without an oral medication for the treatment of podiatry issues.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03781024
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Data Collection Analysis Business Management trials
Trials by the same sponsor.
- NCT03768011 — Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without · unknown
- NCT03322254 — How Respiratory Pathogens Panel Results Affect Patients' Plan of Care · unknown
- NCT03319290 — Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategi · unknown
- NCT03322176 — Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and P · unknown
- NCT03322241 — Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03781024 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Data Collection Analysis Business Management
- Last refreshed: 19 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03781024.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing